Nutraferon LENVA Capsule

Rather than indiscriminately attacking all dividing cells, Lenvatinib selectively blocks VEGFR and FGFR receptor enzymes that tumors use to sprout new blood vessels (angiogenesis) and drive cancer cell growth.

Unresectable Hepatocellular Carcinoma (liver cancer) typically develops in patients with underlying cirrhosis or chronic liver disease; oncologists and hepatologists co-manage weight-based Lenvatinib dosing alongside liver function and portal hypertension care.

Never crush or open the capsules. Instead, dissolve the intact capsules in 1 tablespoon of water or apple juice for 10 minutes, stir for 3 minutes, drink, and rinse the glass with another tablespoon of liquid to swallow the remaining medicine.

Never stop or alter your dose without explicit instructions from your oncologist, as stopping prematurely allows tumor angiogenesis and progression to resume.

In addition to hypertension (which must be controlled before and during treatment), your oncology team will closely monitor for proteinuria/renal impairment (urine protein checks), hepatotoxicity (LFTs), cardiac dysfunction & QTc prolongation, arterial thromboembolism, hypocalcemia, thyroid dysfunction (hypothyroidism), diarrhea/weight loss, palmar-plantar erythrodysesthesia (hand-foot syndrome), GI perforation/fistula, osteonecrosis of the jaw, and i